Infertility and the provision of infertility medical services in developing countries by Ombelet, Willem et al.
Infertility and the provision of infertility medical services
in developing countries
Willem Ombelet1,6, Ian Cooke2, Silke Dyer3, Gamal Serour4 and Paul Devroey5
1Department of Obstetrics and Gynaecology, Genk Institute for Fertility Technology, Schiepse Bos 6, 3600 Genk, Belgium;
2Emeritus
Professor of Obstetrics and Gynaecology, 80 Grove Road, Millhouses, Shefﬁeld S7 2GZ, UK;
3Reproductive Medicine Unit, Department
of Obstetrics and Gynaecology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South
Africa;
4Department of Obstetrics and Gynaecology, Al Azhar University, The Egyptian IVF-ET Center, 3 Street 161, Hadayek El-Maadi,
Cairo 11431, Egypt;
5The Center for Reproductive Medicine of the Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Belgium
6Correspondence address. E-mail: willem.ombelet@telenet.be
BACKGROUND: Worldwide more than 70 million couples suffer from infertility, the majority being residents of
developing countries. Negative consequences of childlessness are experienced to a greater degree in developing
countries when compared with Western societies. Bilateral tubal occlusion due to sexually transmitted diseases and
pregnancy-related infections is the most common cause of infertility in developing countries, a condition that is poten-
tially treatable with assisted reproductive technologies (ART). New reproductive technologies are either unavailable
or very costly in developing countries. This review provides a comprehensive survey of all important papers on the
issue of infertility in developing countries. METHODS: Medline, PubMed, Excerpta Medica and EMBASE searches
identiﬁed relevant papers published between 1978 and 2007 and the keywords used were the combinations of ‘afford-
able, assisted reproduction, ART, developing countries, health services, infertility, IVF, simpliﬁed methods, tra-
ditional health care’. RESULTS: The exact prevalence of infertility in developing countries is unknown due to a
lack of registration and well-performed studies. On the other hand, the implementation of appropriate infertility
treatment is currently not a main goal for most international non-proﬁt organizations. Keystones in the successful
implementation of infertility care in low-resource settings include simpliﬁcation of diagnostic and ART procedures,
minimizing the complication rate of interventions, providing training-courses for health-care workers and incorpor-
ating infertility treatment into sexual and reproductive health-care programmes. CONCLUSIONS: Although recog-
nizing the importance of education and prevention, we believe that for the reasons of social justice, infertility
treatment in developing countries requires greater attention at National and International levels.
Keywords: developing countries; infertility; low-cost ART; politics; simpliﬁed infertility treatment
Introduction
One of the most important and underappreciated reproductive
health problems in developing countries is the high rate of inferti-
lity and childlessness (Bergstrom, 1992; Leke et al., 1993). The
inability to procreate is frequently considered a personal tragedy
and a curse for the couple, impacting on the entire family and
even the local community. Negative psychosocial consequences
of childlessness are common and often severe (Daar and Merali,
2002; Dyer et al., 2002a,b, 2004, 2005; Umezulike and Efetie,
2004; Dyer, 2007, Table I, Fig. 1). In many cultures, womanhood
is deﬁned through motherhood and infertile women usually carry
the blame for the couple’s inability to conceive. Moreover, in the
absence of social security systems, older people are economically
completely dependent on their children. Childless women are
frequently stigmatized, resulting in isolation, neglect, domestic
violence and polygamy (Gerrits, 1997; Sundby, 1997; Papreen
et al., 2000; van Balen and Gerrits, 2001; Richards, 2002; van
Balen, 2002; Araoye, 2003; Hollos, 2003; Wiersema et al., 2006).
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lacking, it is generally believed that more than 70 million couples
suffer from infertility worldwide (Fathalla, 1992; Boivin et al.,
2007). Bilateral tubal occlusion is the most common underlying
cause (World Health Organization, 1987; Nachtigall, 2006), a con-
dition that is potentially treatable by assisted reproductive technol-
ogies (ART). Unfortunately, a large majority of the population
cannot afford infertility treatment since new reproductive technol-
ogies are either unavailable or very costly (Malpani and Malpani,
1992; Van Balen and Gerrits, 2001; Nachtigall, 2006). When
reﬂecting on the possible role of ART in developing countries,
many concerns and barriers become apparent (Dyer et al.,
2002a,b; Fathalla, 2002; Vayena et al., 2002b). Central to these is
the question whether expensive techniques, which have a low
success rate (live birth rate,25% per cycle), can be justiﬁed in
countries, where poverty is still an important issue. A related
concern involves many shortcomings of health-care systems,
which struggle with the immense problem of infectious diseases,
suchasmalaria,tuberculosis,gonorrhoeaandHIV.Furtherbarriers
include national and international health strategies, which during
the past decades have focused on reducing total fertility rates (the
so-called political ‘top-down’ perspective), while infertility care
has received little or no attention (Hamberger and Janson, 1997).
In this paper, we will discuss controversies and common mis-
conceptions surrounding this subject, outline the magnitude of
the problem, evaluate infertility-related health policies of inter-
national organizations tasked with promoting global reproductive
health care, and present strategies for infertility prevention and
treatment in resource-poor settings.
Methodology—search strategy
This search aimed to identify all valuable and relevant information
considering the problem of infertility in developing countries pub-
lished between January 1978 and May 2008. We referred the infor-
mation databases of Medline, PubMed, Excerpta Medica and
Table I. Psychological and social consequences of infertility in
developing countries.
(1) Loss of Social Status (Dyer et al., 2002a,b, 2004)
† Fertility ¼ blessing of God ! Infertility ¼ curse, punishment
† Social status of woman ¼ dependent of number of children (sons)
† Burdened with additional social tasks by extended family
(2) Social Isolation (Dyer et al., 2004)
† Subject to ridicule, scorn and gossip
† Marginalized in family/community
† Excluded from community functions
† Accusations of ‘witch craft’, ostracism
† Excluded from contact with children
(3) Marital Instability (Dyer et al., 2002a,b, 2004; Orji et al., 2002;
Umezulike and Efetie 2004)
† Unhappiness, sexual dissatisfaction
† Alcohol abuse
† Migrant Labour
† Psychological, emotional and physical abuse
† Abandonment//divorce
Return of bride wealth
Poverty
Second wife
Strategy to overcome infertility
Increased risk of STDs including HIV
(4) Loss of Social Security (Sundby et al., 1998; Papreen et al., 2000;
Hollos, 2003)
† Marital instability ) lack of assistance in domestic tasks
† Land claims negotiated through number of children
† Lack of old age security
† Death of a spouse:-few rights to inherit from husband
-right to live in deceased husband’s compound
dependent on the presence of a son.
(5) Gender Identity (Hollos, 2003; Dyer et al., 2004)
† Infertility arrests transition from child to adult
(6) Psychological consequences (Papreen et al., 2000; Dyer et al., 2004)
† Most common: guilt, depression, shame, grief, disbelief, sense of
worthlessness
† Greater width and depth of distress when compared with Western
Societies
(7) Continuity: Funeral Tradition (Leonard, 2002; Hollos, 2003)
† No child to conduct funeral/mourn for deceased
† No burial//fear for diminished fertility of the soil
† Infertile women excluded from reincarnation
Figure 1: Consequenses of infertility: in developed countries, the conse-
quences of infertility rarely extend beyond level 2, in developing countries
(especially Asia and Africa) the consequences are infrequently as mild as
level 3.
The distinction between social alienation, social isolation, economic stress,
severe economic deprivation and mild to very severe physical violence was
clearly described before (Daar and Merali, 2002; Vayena et al., 2002a, p. 18).
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606EMBASE, and the keywords used were the combinations of
‘affordable, assisted reproduction, ART, developing countries,
health services, infertility, IVF, simpliﬁed methods, traditional
health care’. In our view, ART include any form of assisted repro-
duction, including IVF/ICSI and ovarian stimulation with or
without artiﬁcial insemination.
Abstracts had to be written in English and if the abstract was
pertinent and relevant to the topic, the full article whether in
English, German or French was sought and critically studied in
detail.
Other sources include Google using the same keywords and the
websites of different organizations, such as ESHRE, IFFS, FIGO,
WHO, Population Council, Family Planning International, Joyce
Fertility etc. We also referred books and monographs on the issue
of childlessness in developing countries. In addition, the reference
lists and bibliography of all relevant studies and papers were
reviewed and manually searched for additional papers.
We excluded studies and reports with minimal importance on
the topics, and we wanted to study prevalence of infertility, aetio-
logical factors, ethical and sociocultural inﬂuences, diagnostic and
therapeutic procedures and governmental and non-governmental
initiatives. We also excluded studies with a small group size
since these reports are frequently associated with a poor methodo-
logical quality. Some opinions in the paper are inﬂuenced by
several personal contacts with experts in the ﬁeld. Since no ran-
domized trial could be found on our subject, only observational
and descriptive studies are discussed in this review.
For the classiﬁcation of developing countries, different
measures have been described by the World Bank and the
United Nations Development Programme (UNDP). The World
Bank classiﬁes countries according to their gross national
income whereas the UNDP takes into consideration three criteria
for the evaluation of countries’ development: the low-income
criterion, the economic vulnerability criterion and the human
resources weakness criterion (Sallam, 2008). In our review, we
included studies and reports from all countries outside Europe,
North America, Japan and Australia/New Zealand because most
of these countries are known to need assistance for reproductive
health care regardless of their exact classiﬁcation.
Prevalence of infertility in developing countries
Only a limited number of papers report on the prevalence of
infertility in developing countries. According to Boivin et al.
(2007), the 12-month prevalence rate ranges from 6.9 to 9.3% in less-
developed countries. Substantial geographical differences in the
prevalence are noted, and these differences are largely explained
by different environmental, cultural and socioeconomic inﬂuences.
In sub-Saharan Africa, the prevalence differs widely from 9% in
the Gambia (Sundby et al., 1998) and 11.8% in Ghana (Geelhoed
et al., 2002) compared with 21.2% in northwestern Ethiopia
(Haile, 1990) and between 20 and 30% in Nigeria (Ebomoyi and
Adetoro, 1990; Adetoro and Ebomyi, 1991; Okonofua, 1996;
Larsen, 2000). Even less data are available from Asia and
Latin-America, but a report compiled by the World Health
Organization (WHO) indicated that the prevalence of infertility
in these regions fell within the globally expected range 8–12%
of couples of reproductive age and was thus lower when compared
with African countries (World Health Organization, 1991).
Aetiology and risk factors for infertility
in developing countries
In a large study performed by the WHO Task Force on the
Diagnosis and Treatment of Infertility, 8504 infertile couples
in 33 different countries were examined through a standard
approach in all participating centres (Cates et al., 1985; World
Health Organization, 1987). In Africa, over 85% of women
had an infertility diagnosis attributable to an infection compared
with 33% of women worldwide. In another study from sub-
Saharan Africa, a history of sexually transmitted diseases
(STDs) was reported by 46% of participating men (Gerais and
Rushwan, 1992). A study of 5800 couples in 33 World Health
Organization centres in 25 countries showed that almost 50%
of the African couples and 11–15% of other patients in other
parts of the world had infectious tubal disease (Sciarra, 1994).
Individual studies from Nigeria, South Africa and Egypt have
reported a prevalence rates of tubal factor infertility ranging
from 42 to 77% (Otolorin et al., 1987; Okonofua et al., 1989;
Otubu et al., 1990; Serour et al., 1991; Chigumadzi et al.,
1998; Ikechebelu et al., 2003). It has been estimated that
 70% of pelvic infections are caused by STDs while the other
30% are attributable to pregnancy-related sepsis (Ericksen and
Brunette, 1996). Similarly, most cases of male factor infertility
are caused by previous infections of the male genitourinary
tract (Kuku and Osegbe, 1989; Meheus et al., 1986). Nigerian
studies have shown a prevalence of male infertility in 26–43%
of cases (Adeniji et al., 2003; Ikechebelu et al., 2003; Olantunji
and Sule-Odu, 2003). Studies from non-African developing
countries on the causes of infertility are lacking but available
data would indicate that infection-related causes also play a pro-
minent role (Barten, 1978; Makush et al., 2000).
Moreover, infectious diseases other than STDs may also cause
infertility. Lepromatous leprosy is associated with an increased
risk of semen abnormalities and azoospermia with testicular biop-
sies showing features of spermatogenic arrest as well as complete
hyalinization of both seminiferous tubules and interstitial tissue
(El-Beheiry et al., 1979; Saporta and Yuksel, 1994). Data from
Tanzania have suggested lower fertility in men and women suffer-
ing from malaria although the pathogenesis remains to be
explained (Larsen, 1996).
Sexually transmitted diseases
STDs are, as outlined above, prominent risk factors for infertility
in developing countries. The organisms most commonly involved
are Chlamydia trachomatis and Neisseria gonorrhea (Walker
and Hoﬂer, 1989; Mascie-Taylor, 1992; Mayaud et al., 1995;
Sciarra, 1997). Pelvic tuberculosis can also result in tubal inferti-
lity, and high incidences have been reported in studies from the
Indian subcontinent as well as from Ethiopia (Mascie-Taylor,
1992; Parikh et al., 1997; Sekadde-Kigondu and Machoki, 2002;
Shaheen et al., 2006).
Another sexually transmitted organism associated with inferti-
lity is HIV-1. Several studies have documented reduced fecundity
in HIV-infected individuals (Brocklehurst and French, 1998;
Glynn et al., 2000; Sekadde-Kigondu and Machoki, 2002). Mech-
anisms involved include tubal factor infertility through the greater
susceptibility to other STDs, male hypogonadism, altered sperma-
togenesis, increased risk of miscarriages as well as behavioural
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On the other hand, marital instability and polygamy secondary
to infertility may in turn increase the spread of HIV-1 infection
(Nabaitu et al., 1994).
The high prevalence of infections is commonly compounded
by a delayed or a complete lack of diagnosis together with incom-
plete, inappropriate or no intervention at all (Adler, 1996;
Giwa-Osagie, 2002a,b). Related risk factors include, among
others, poor education, poverty, negative cultural attitudes to
women,earlyageatﬁrst marriage,polygamy,lackofaccesstocon-
traception and the adverse effects of migrant labour (Bambra,
1999). Effective and appropriate educational, preventive and cura-
tive sexual and reproductive health programmes are urgently
required (Leke et al., 1993; Temmerman, 1994). A diagram of
the most important aetiological factors associated with infertility
in developing countries is shown in Fig. 2.
Unsafe abortion practices
Worldwide estimates for 1995 indicate that  20 million illegal
abortions took place every year and almost all unsafe abortions
(97%) occur in developing countries (Henshaw et al., 1999;
World Health Organization, 2004). Unsafe abortions are com-
monly carried out by unqualiﬁed personnel without the requisite
skills, or in unsafe and unsterile conditions (Leke et al., 1993;
Grimes et al., 2006). Even if performed under legal circumstances
abortion practices are, however, often not within the required stan-
dard of care. In the case of complications, access to appropriate
medical treatment is often insufﬁcient (Leke et al., 1993).
Post-partum pelvic infections
Post-partum pelvic infections are extremely common in developing
countries. They are often the result of lack of access to appropriate
medical care, especially in rural areas. Home deliveries, performed
in unhygienic circumstances by inadequately trained or equipped
birth attendants, increase the risk of complications and post-partum
infections dramatically. In sub-Saharan Africa, only 40% of births
are attended by trained personnel (Stanton et al., 2007). The most
important complications of obstructed or unassisted labour are
trauma and sepsis, both of which increase the risk of future inferti-
lity. In addition, obstetric ﬁstulas may also compromise reproduc-
tive potential. The mechanisms involve chronic inﬂammation as
well as social isolation, which these women often suffer as a
result of incontinence and subsequent rejection by their husband,
family and community (Leke et al., 1993).
Female genital mutilation
It has been estimated that between 100 and 140 million girls and
women have been subjected to some form of female genital
Figure 2: Infection-related infertility in developing countries: causes and consequences.
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Middle East (World Health Organization, 2005). Traditionally, the
procedure is performed by local midwives or elderly female villa-
gers who have learned the techniques form their predecessors and
who often have limited knowledge about the principles of aseptic
techniques and the underlying anatomy (Davis et al., 1999). The
procedure is associated with immediate and long-term compli-
cations which include haemorrhage, sepsis, haematocolpos, dys-
menorrhoea, dyspareunia, obstructed labour, ﬁstula formation
and infertility (Davis et al., 1999; Obermeyer, 2005). In order to
avoid these complications, some parents choose to use biomedical
services if these can be accessed, indicating that the procedure
may be gradually modernized but not necessarily abandoned.
Controversies and common misconceptions surrounding
the issue of infertility treatment in developing countries
Population growth perception
In the Western industrialized World, the idea of infertility treat-
ment in developing countries often evokes a feeling of discomfort
and disbelief. It is generally thought that the problem of overpopu-
lation can only be solved by well-organized family planning pro-
grammes and education, leaving little room for other initiatives. In
this context, some believe that the infertile couple should be
encouraged to courageously accept their condition of childlessness
rather than be offered intervention (Tangwa, 2002).
A few questions around this subject are crucial: (1) Is it still true
that the expected overpopulation in developing countries is mainly
caused by the high fertility rate? (2) Can we succeed at reducing
the high fertility rate through promotion of contraception and at the
same time offer infertile couples the opportunity of simpliﬁed diag-
nosisandtreatment?and(3)Whatwouldbetheexpectedimplication
on population growth if affordable infertility treatment, including
ART, could be offered to infertile couples in developing countries?
Considering the ﬁrst question: according to the United Nations
data the world population is expected to increase from 6.7 billion
inhabitants in 2005 to reach 9.2 billion in 2050 (United nations,
2007, p. vii). By 2050, the population of the more developed
countries will decline slowly by  1 million a year, while that of
the developing world would be adding 35 million annually, 22
million of whom would be absorbed by the least developed
countries. On the other hand, it should be noticed that if fertility
remains constant at the levels estimated for 2000–2005, the popu-
lation of the less developed regions would increase to 10.6 billion
instead of the 7.9–9.2 billion. To achieve reductions against these
estimates, it is essential that access to family planning services
expands in the least developed countries. Therefore, it should be
clear that the ﬁgures are based on assumptions of future fertility
rates declining (United Nations, 2007, p. viii).
The global fertility rate (number ofchildren per woman) was 5.0
in 1950–1955, 4.5 in 1970–1975 and 2.75 in 2005–2010 (United
Nations, 2007, p. 74).This rate is projected to decline further to
2.02 per woman by 2045–2050, i.e. below the replacement level
of 2.1. In the majority of developing countries, the mean fertility
rate has already dropped as low as 2.58 per woman and is expected
to decline to 1.92 by mid-century.
On the other hand; expected population growth in developing
countries can not only be attributed to high fertility rates but
will also be caused by improved life expectancy (United
Nations, 2007, p. 14). Because of a rapid decline in mortality,
even in the least developed countries life expectancy is set to
rise from an average of 54 years currently to 67 years in 2045–
2050, which highlights the important issue of population ageing.
For Africa, the life expectancy at birth is expected to rise from
53 years nowadays to 66 years in 2045–2050.
Concerning the second question, although family planning and
educational programmes have already resulted in a substantial fer-
tility decline in most developing countries, there is still a need to
support and optimize these programmes. The focus, however,
should be on reproductive autonomy and not primarily on fertility
reduction. The message of including infertility care in Reproduc-
tive Health Care Centres might convince some politicians to
increase their awareness for better family planning strategies
(A. Tezikuba, personal communication). The objective of support-
ing family planning programmes while providing treatment to the
infertile couple can be achieved through the integration of family
planning, fertility and maternal health services in well-organized
existing or newly created Reproductive Health Care Centres.
Lastly, data from Belgium have shown that ART accounted for
only 4.3% of all neonates born in 2004 (source: Study Centre for
Perinatal Epidemiology, Brussels). However, in Belgium, six
cycles of IVF are reimbursed by the government, which implies
that there is no ﬁnancial burden for patients in starting ART pro-
cedures. Even if ART could be made more accessible in developing
countries, it would probably still account for ,1% of all deliveries.
Increasing effort on family planning and health education should
readily overcome this small contribution to the fertility rate.
An overview of the pros and cons of infertility treatment in
developing countries is shown in Table II.
Competition for funding—the limited resources argument
Bilateral tubal blockage is the leading cause of infertility in devel-
oping countries (see section on ‘aetiology of infertility’). While
ART remains the most effective intervention for this condition,
funding remains a contested issue. This can be explained by the
scarcity of health resources against a backdrop of limited funds
In Nigeria the cost of starting a new IVF-programme in a teaching
hospital has been estimated at $2 million, which is more than half
of the total ﬁnancial resources of the hospital (Okonofua, 1996).
Such a strategy is of course unrealistic because hospitals also
have to provide other important (life-saving) health-related ser-
vices within the existing limited budget.
Health authorities focus on primary health care such as the
reduction of maternal mortality and the promotion of family plan-
ning (Aboulghar, 2005). Although prevention of STDs and
pregnancy-related sepsis should be considered a reproductive
health priority, public investment in infertility treatment must
also become a subject for discussion. We can, however, anticipate
that public funding of infertility-related health care will be
restricted to education and preventative care unless we succeed
in substantially simplifying ART procedures.
Geographical differences in attitudes on infertility
with emphasis on sociocultural, religious
and political health issues
In communities which place a high value on fertility and children,
the inability to conceive creates many psychological, social and
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2005; Wiersema et al., 2006). Infertility has a profoundly negative
impact on reproductive health in developing countries, although
this impact varies between different regions and is inﬂuenced,
among others, by religious, sociocultural and legal factors.
The middle east
Three major religions, Islam, Judaism and Christianity,continue to
inﬂuence behaviour, attitudes and policy-making in the Middle
East (Serour, 2000, 2002). To date, ART guidelines for Christians
and Muslims are almost the same. For all religions, artiﬁcial inse-
mination with husband’s semen is permissible. For the Jewish
masturbation should be avoided if possible, so that coitus interrup-
tus or the use of a condom become preferred methods for semen
collection. Judaism allows the practice of all techniques of assisted
reproduction when the oocyte and spermatozoon originate from
the wife and husband, respectively (Schenker, 2005).
Ultraorthodox Jews use infertility treatment as citizens of a prona-
talist state and pronatalist religious system (Kahn, 2002). Third
party gametes are also unacceptable to Muslims, so gamete-
donation, embryo-donation and surrogate motherhood are not
allowed. In contrast, for the Shariaa sect, oocyte donation,
embryo donation and surrogacy within a frame of temporary mar-
riage arrangements are permitted (Serour, 2006). The attitude
towards reproductive practice differs among the various divisions
of Christianity. The practice of assisted reproduction is not
accepted by the Vatican, however, it may be practiced by Protes-
tant, Anglican and other denominations (Schenker, 2000).
Sub-Saharan Africa
Fertility and parenthood are highly valued in Africa to the extent
that procreation is usually considered the most important
purpose of marriage (Okonofua et al., 1995; Hollos, 2003). As a
result, infertility is often associated with marital instability and
many other psychosocial consequences (Table I). Moreover, the
high premium placed on fertility may act as a relevant barrier to
the success of family planning strategies due to the wide-spread
belief that contraception may result in permanent infertility.
There is, in principle, an enormous demand for ART in African
countries, especially because most infertility cases are infection-
related and therefore best treated by ART. Clinics providing
ART are, however, still few and mostly in private settings
(Giwa-Osagie, 2002a,b,c). Before ART can be made more acces-
sible, many challenges will need to be negotiated. These relate to
funding, geographical barriers and to the infrastructure required
for ART (e.g. human skills and resources, equipment and supplies,
electricity etc). The up-to-date management of the adverse effects
of ART, and the need for adequate obstetric and neonatal care are
also very important (Okonofua, 1996; Inhorn, 2003). Moreover,
ART should be implemented with due recognition of the import-
ance and inﬂuence of traditional systems of health and healing
(Sundby, 1997; Leonard, 2002; Tangwa, 2002).
Latin America
Latin America is a heterogeneous region with many different cul-
tural and sociological inﬂuences (Luna, 2002). The high preva-
lence of catholicism has a great impact on reproductive issues.
Although infertility is a social stigma in Latin American societies,
most countries do not consider ART a priority. Public hospitals
generally provide only infertility investigations but cannot offer
ART. Private centres exist but are very expensive, and therefore
ART is commonly perceived as a luxury for wealthy couples
(Zegers-Hochschild et al., 2008). Paradoxically, those who
cannot access ART are those who are most in need of treatment,
as they are most likely to suffer from STDs, be subjected to
unsafe abortion practices or work in conditions with pollutants
inﬂuencing their reproductive capacity (Luna, 2002).
In 1995, a multinational registry of ART was initiated. Today
this registry comprises  135 centres in more that 10 countries in
Latin America (Registro Latinamericano deReproduccion Asistida,
www.redlara.com). Legislation on ART procedures differs between
countries and is only well regulated in Mexico and Brazil. In these
countries, ART can only be offered to married couples or those
with a stable relationship. Embryo cryopreservation can and
embryo donation cannot be done. While there is a need for better
Table II. Pros and cons of infertility treatment in developing countries (DC).
Arguments pro
† Infertility is a disease and needs medical treatment
† High prevalence of tubal factor infertility in developing
countries (DC)
† Negative consequences of childlessness are much stronger in DC
† Equity: IVF should not only be available for the rich
† Prevention and alternative methods are not always successful
† Adoption is not an option in most DC (socio-cultural, religious)
† Possibility of simplifying diagnostic procedures
† Possibility of simplifying clinical procedures (IVF-cycle)
† Possibility of simplifying laboratory procedures (IVF)
† Opportunity of establishing ‘Reproductive Health Care Centres’
with possibilities for family planning/mother-care/infertility
diagnosis & treatment
† Opportunity for cervical cancer and HIV screening for subfertile
couples
Arguments contra
† Reproductive Health Care in DC
† More important priorities -family planning (contraception)
-prevention of infections
-education
† Limited budgets -from government
-from non-governmental
organizations
† Other important priorities: vaccinations, malaria, HIV,....
† Dilemma: overpopulation versus childwish
† IVF-related procedures: regarded as expensive and moderately
effective
† High risk for complications (ovarian stimulation syndrome
(OHSS), multiple pregnancy, prematurity,...)
† Unknown outcome for women in this population (? cancer risk)
† Immediate and long-term-risks for ART babies
† Limited professional experience for medical and paramedical staff
in DC
† Low-level facilities in most DC
† ICSI and cryopreservation of gametes and embryos: doubts about
cost-effectiveness in DC
Reprinted from an article in Reproductive BioMedicine Online by Ombelet
and Campo (2007) with permission from Reproductive Healthcare Ltd.
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610regulation in many countries, the fear of the emergence of very
restrictive laws due to the inﬂuence of a strong Catholic lobby may
actasadeterrentinthisregard.Atthesametimethelackofregulation
is associated with a greater degree of fear regarding laboratory pro-
cedures and ART (Guilhem, 2001). Clearly, there is a need for
open dialogue and debate surrounding the issue of ART in Latin
America in order to improve access and quality of infertility care.
India
Motherhood is the most important goal for Indian women. Chil-
dren, especially boys, give the woman status as well as psycho-
logical and emotional security within the patriarchal family.
Childlessness is associated with stigmatization, social isolation
and sometimes violence (Unisa, 1999; Riessman, 2000). Even in
the case of male infertility, women usually bear the negative con-
sequences of their inability to conceive. Preventive and curative
services for infertility have not yet been a priority in India
despite the importance of motherhood. ART is only provided in
private centres and is only accessible by those who can afford
this treatment. Owing to the stigma of infertility, secrecy is an
important component of assisted conception, especially where
donor gametes are involved (Bharadwaj, 2003). Owing to the
lack of laws and regulation, there is great concern about quality
and safety within existing ART centres. The problem of infertility
in India has to be interpreted in a context of poverty, class and
gender inequality and unequal access to health-care resources
(Widge, 2002).
The Far East—China
China has developed a unique culture inﬂuenced by the teachings
of Taoism, Confucianism and Buddhism. People with Confucian
or Buddhist beliefs consider infertility as retribution for wrong-
doing either by the man, woman or even ancestors (Handwerker,
1995; Qiu, 2002). Excessive sexual activity is believed to be the
reason of infertility. With this belief, one can expect that infertile
people are mostly blamed for their condition.
IVF-related procedures are acceptable when a couple’s own
gametes are used. On the other hand, donor insemination is also
widely practised although the availability of donors does not
meet the demand. In general, any intervention in natural reproduc-
tion is not desirable, but interference seems to be more acceptable
than childlessness. Another form of interference relates to sex-
selection which is especially practised in rural areas where boys
are more highly desired than girls, and which may create devastat-
ing consequences for female embryos (Handwerker, 2002).
Suggested strategies for affordable infertility
management in developing countries
The time has come to consider the possibility of implementing
‘new reproductive technologies’ in developing countries. We con-
sider the integration of infertility management into sexual and
reproductive health-care programmes and a reduction of costs a
prerequisite in this regard. Simplifying diagnostic procedures in
the infertility work-up, simplifying ART, minimizing compli-
cation rates and organizing training courses for medical and para-
medical personnel will be mandatory if new reproductive
technologies are becoming available and affordable, especially
outside the private health-care sector.
Preventive strategies
The ﬁrst priority should always be prevention rather than cure
(Inhorn, 2003). Therefore, prevention of STDs and pregnancy-
related sepsis should be regarded as the most important and cost-
effective strategy to decrease infertility rates. Many variables
inﬂuence the success of the different prevention strategies.
These include a number of elements: the target group, the con-
straints to overcome and the right strategies for prevention
(Table III, Sekadde-Kigondu et al., 2002; Kiros, 2002; Leke,
2002; Leke et al., 2002).
The importance of education was documented by Okumu et al.
(1990) who studied the past reproductive and sexual character-
istics of patients with tubal infertility. When compared with
fertile controls, women with tubal disease were younger at ﬁrst
coitus, were more likely to have had ﬁrst coitus pre-menarche,
had more sexual partners, more abortions before marriage, more
Table III. Prevention of Infertility in developing countries.
Target Group
† Adolescents and young adults with high-risk behaviour
† Low socio-economic class
† Migrants from rural to urban areas
† Refugees
† High-risk professions: tourist guides, long distance truck drivers, sex
workers etc.
Constraints to overcome
More urgent issues: HIV pandemic, high maternal and perinatal mortality
rates,....
Lack of political commitment
Lack of knowledge on societal impact on the magnitude of ‘infertility
problems’
Stigmatization and gender issues associated with HIV/STDs
No integration of infertility in Reproductive Health Care Centres
- understafﬁng, lack of training, no knowledge of prevention and
management of infertility
Poorly organized fertility clinics
- lack of space for proper counselling and laboratory facilities
Lack of clear guidelines//lack of well-organized referral system
Poor planning of preventive strategies
Men’s lack of interest in a ‘fertility exploration’
Popularity of traditional healers performing harmful traditional practises
Lack of available drugs and restrictions on drug prescription
Strategies for prevention
Education: " public awareness
" knowledge of adolescents in human sexuality, reproductive
biology, awareness of fertile period, causes of infertility etc.
Community mobilization: target groups ¼ NGOs, health committees,
opinion leaders
Prevention and effective treatment of STDs in men is vital: primary source
of infection
Prevention of unplanned pregnancies (friendly family planning)
Safe delivery and post-natal care
Safe abortion services when law permits
Linkage of family planning, mothercare and infertility care
! creation of centres of excellence
STD, sexually transmitted disease; NGO, Non-governmental organization
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STDs and had fewer years of schooling. These data suggest that
reproductive and sexual events during teenage years determine
the future prospects of fertility and highlight the importance of
education. Paradoxically, education will not only help to safeguard
future fertility but will also reduce total fertility rates as studies
have demonstrated that education, especially of women, is an
important variable determining the desired number of children
(Potts and Marks, 2001; Bauer et al., 2006).
Simplifying diagnostic procedures
An accurate history of couple’s personal and medical details
together with a simple light microscopy semen analysis will
identify the majority of infertility problems related to ovulatory
disorders and male subfertility (Ombelet et al., 1997a, 1998;
World Health Organization, 1999; Menkveld et al., 2001; Gunalp
et al., 2001). The diagnosis of tubal factor infertility can be
made by hysterosalpingography (HSG) or hystero-salpingo-
contrast-sonography. These techniques are simple, reliable and
comparatively inexpensive (De Muylder, 1995; Hauge et al.,
2000; De Jonge et al., 2001; Kiguli-Malwadde and Byanyima,
2004). Laparoscopic techniques have been simpliﬁed over the
years andcan now beconductedin aone step ambulatory approach
(Brosens et al., 2002; Gordts et al., 1998, 2002; Campo et al.,
2005). Even ofﬁce mini-hysteroscopy can be done without major
costs and side-effects, provided there has been appropriate training
(Campo et al., 1999; Ombelet and Campo, 2007).
Moreover, all of these procedures can be performed by a small
team of health-care providers within a short period of time in an
inexpensive setting (Ombelet and Campo, 2007). Future studies
should assess the value and potential costs of ‘one-stop infertility
clinics’ in different developing countries.
Simpliﬁed infertility treatment and non-IVF assisted reproduction
Fertility awareness programmes are an inexpensive and efﬁcient
ﬁrst line approach to infertility management, provided tubal
patency is demonstrated and severe male factor subfertility has
been excluded (Gnoth et al., 2002). In a prospective randomized
study by Gnoth et al. (2003), couples were instructed about the
meaning and detection of cervical mucus secretion, with good
results. Fertility awareness counselling, which should also incor-
porate education on infertility prevention, can be given by
nurses and paramedical staff working in existing reproductive
health-care centres.
For ovulatory dysfunction, representing almost 20% of female
infertility, clomiphene citrate (CC) can initiate ovulation.
This medication is very cheap, can be taken orally with minimal
discomfort and the results are rewarding. Ovulation can be
induced in 50–70% of cases and, together with timed intercourse,
the pregnancy rate variesbetween 15and25% per cycle with alow
multiple pregnancy rate of 6–8% (Ombelet et al., 1996, 1997b;
Sovino et al., 2002). In case of resistance to CC, a low-dose
ovarian stimulation regimen with gonadotrophins aimed at mono-
follicular growth is advisable, although this medication is more
expensive. Alternatively, the use of aromatase inhibitors (AI)
such as anastrozole and letrozole may be considered (Begum
et al., 2006; Verpoest et al., 2006; Casper, 2007; Kafy and
Tulandi, 2007). Although more expensive than CC, success rates
may be slightly higher when compared with CC, probably due
to a better endometrial, receptivity (Atay et al., 2006).
In the case of unexplained and moderate male factor infertility
and provided tubal patency has been documented, intrauterine
insemination (IUI) with husband’s semen in natural cycles or
after CC-stimulation can be promoted as a ﬁrst-line treatment
without major costs and without expensive infrastructure
(Ombelet et al., 1995, 2003; Verhulst et al., 2006). Cost-
effectiveness studies showed that three IUIs were as successful,
but much cheaper than one IVF/ICSI cycle (Peterson et al.,
1994; Zayed et al., 1997; Goverde et al., 2000; Philips et al.,
2000; Van Voorhis et al., 1997; Van Voorhis and Syrop, 2000).
Moreover, IUI programmes can be run by well-trained paramedi-
cal staff, another advantage for resource-poor countries. Con-
trolled ovarian hyperstimulation (COH), with or without IUI, is
associated with the risk of multiple gestation, especially when
gonadotrophins are used (Gleicher et al., 2000). A high degree
of awareness must be maintained, underpinned by appropriate pro-
tocols in order to minimize this risk. This is a particularly import-
ant issue in developing countries where the consequences of
multiple pregnancies can be devastating.
Endoscopic surgery
Laparoscopy is an important tool, not only in the diagnosis of
infertility, but also in the treatment of selected cases. Hystero-
scopy may be used to diagnose and treat uterine septa, endometrial
polyps, submucosal myomas and intrauterine adhesions. At
laparoscopy, ovarian drilling can be performed in the case of ovu-
latory disorders associated with polycystic ovary syndrome
(PCOS) when weight reduction and/or CC are unsuccessful
(Guzick, 2007). Laparoscopic surgery can be recommended in
the case of large ovarian cysts or hydrosalpinges, before starting
assisted reproduction (Strandell et al., 2005). This implies that
training in endoscopic surgery should be regarded as an important
issue in developing countries.
Simpliﬁed assisted reproduction
The development of ART associated with low cost and a very low
complication rate is mandatory if governments in developing
countries are to be convinced to fund infertility clinics. IVF pro-
cedures can be modiﬁed to make them affordable. Presently we
do not know if IVF, even minimal stimulation IVF, is feasible in
less than ideal conditions when compared with centres with high
standards of laboratory equipment and using standard stimulation
protocols. Therefore, studies on simpliﬁed, low-cost diagnostic
procedures and ART techniques are urgently required in a
low-cost setting.
Recruiting oocytes for IVF: ovarian stimulation
Gonadotrophins and/or follicle stimulating hormones, GnRH ago-
nists and GnRH antagonists are too expensive to be used routinely
in developing countries. If used without sufﬁcient experience they
also carry a high risk of ovarian hyperstimulation syndrome
(OHSS), a life threatening disease. Mild ovarian stimulation
should therefore be considered as a potential option in resource-
poor countries (Philips and Kadoch, 2007).
The results of natural cycle IVF are, however, disappointing.
The efﬁcacy is hampered by high cancellation rates because of
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612premature LH rise and premature ovulation(Pelinck et al., 2002). A
low-risk and patient-friendly strategy is minimal stimulation IVF
aiming at monofollicular growth. In the late follicular phase, a
GnRH antagonist is given to prevent ovulation together with FSH
forsubstitution(Pelincketal.,2006).Theoverallongoingpregnancy
rate per started cycle is low (8.3%) with an acceptable cumulative
ongoing pregnancy rate of 20.8% after three cycles. Alternatively,
low-dose hCG can be administered in the later stages of controlled
ovarian stimulation. This results in a signiﬁcantly reduced dose of
recombinant FSH/hMG while the outcome is comparable to tra-
ditional COH regimens (Filicori et al., 2005a,b).
The use of a low-dose CC regimen in IVF is another option with
reportedly acceptable results, minimal side effects and a very low
complication rate (Steinkampf et al., 1992; Massey et al., 1994;
Ingerslev et al., 2001; Hovatta and Cooke, 2006). The use of
CC-stimulation seems to be superior to natural or minimal stimu-
lation IVF (Daya et al., 1995; Ingerslev et al., 2001; Nargund
et al., 2001). Another option might be the use of letrozole or
low-dose stimulation with gonadotrophins or recombinant FSH
(more expensive). Identical results were reported with this
low-dose protocol of recombinant FSH when compared with the
commonly used high-dose stimulation protocols (Hohmann
et al., 2003). A higher cancellation rate before oocyte retrieval
was compensated by improved embryo quality concomitant with
a higher chance of undergoing embryo transfer. Cumulative
rates of term live birth and patient discomfort are much the
same for mild ovarian stimulation with single embryo transfer
and for standard stimulation with two embryos transferred. The
important advantage is that a mild IVF treatment protocol can
substantially reduce multiple pregnancy rates and overall costs
(Heijnen et al., 2007).
Monitoring of the IVF cycle
Monitoring of follicular development in an IVF cycle, as well as
the timing of the hCG administration can be done solely on sono-
graphic criteria with basic inexpensive ultrasound equipment
thereby avoiding the need of expensive endocrine investigations
(Steinkampf et al., 1992; Rojanasakul et al., 1994).
Simpliﬁed laboratory procedures and equipment
Lowering the cost associated with laboratory procedures, namely
fertilization and culture of embryos, represents another challenge.
One possible approach is the use of a ‘humidicrib’, a plastic box
which is commonly used for keeping newborns snug, instead of
an expensive laminar ﬂow hood (Hovatta and Cooke, 2006;
Pilcher, 2006). For a tenth of the price, this box can be modiﬁed
to be used as a portable, near sterile environment for the handling
of gametes and embryos. Expensive cylinders of carbon dioxides
required to incubate the embryos may be abandoned in favour of
exhaling across the culture medium before sealing it in a plastic
bag. This bag, containing the Petri dish with the embryos, can
be dropped into a warm bath without the need for expensive incu-
bators. This technique has been successfully used for more than 10
years for cow embryos in veterinary IVF (Vajta et al., 1997, 2004).
Another possibility is intravaginal or intrauterine fertilization
and culture. Intravaginal culture was already described about 20
years ago (Ranoux et al., 1987, 1988; Ranoux and Seibel, 1990;
Taymor et al., 1992). A tube ﬁlled with 3 ml of culture medium
containing 1–5 oocytes with 10 000–20 000 washed spermatozoa
per millilitre is hermetically closed and is placed in the vagina and
held by a diaphragm for incubation for 44–50 h. Comparable
success rates with conventional IVF were reported (Ranoux
et al., 1988). For unknown reasons, this simple and safe method
of culture did not receive wide attention.
Semen decontamination through sperm processing is very
important in countries with a high rate of seminal infection.
The use of a novel washing method combining multiple density
gradients and trypsin for removing human immunodeﬁciency
virus-1 and hepatitis C virus from semen seems to be very
promising (Loskutoff et al., 2005; Huyser et al., 2006).
Table IV summarizes the most important recommendations to
consider when starting an ART unit in developing countries.
Minimizing the risks and complications of ART—OHSS
and multiple pregnancy
The two most important complications of ART are OHSS and
multiple pregnancies. If left untreated, OHSS can result in
serious health complications and even death. OHSS is mostly
associated with the high serum estradiol level from the use of
high dose gonadotrophins and/or recombinant FSH.
Multiple pregnancy is the most important adverse outcome of
ART. Perinatal and maternal mortality/morbidity rise dramati-
cally compared with singleton pregnancies (Elster, 2000; Cohen,
2003; Ombelet et al., 2005). Almost 50% of twin pregnancies
are associated with preterm labour and/or preterm prelabour
rupture of membranes (PPROM) often leading to premature
delivery (,37 weeks) and its related morbidity and mortality
(The ESHRE Capri Workshop Group, 2000). Two out of three
Table IV. Most important recommendations to consider when starting
low-cost ART in developing countries: a proposed strategy (C. Huyser:
personal communication at the Arusha Expert meeting, 2007).
(1) Risk analysis of the country
(2) De-stigmatizing of fertility problems
(3) Identifying patients through reproductive health screening
(4) The community/region should be empowered to support the program
(communication channels, ...)
(5) Be aware of infectious conditions and STDs
WAseptic conditions to perform procedures
WScreening of patients
WPrevention of STD transmission
WUnique proﬁles and risks in different countries
WEffective semen decontamination methods for sperm processing
(6) ART should be designed to be robust, repeatable and efﬁcient
(7) Equipment should be basic, sturdy and strong
(8) Products should be solid, ready to use and with a long half-life
WSperm processing materials are best aseptically packaged (set or kit)
and stored at room temperature
WEmbryo culture media should be robust, short-term, pre-packaged in
small quantities
WDisposables (pipette tips, screening dishes,....) can be pre-packaged
as ‘a set per patient’
(9) The use of silastic condoms might be needed in some communities
(10) Information to the community should be discrete and applicable, taking
into account sociocultural and religious differences
(11) A training program (with follow-up/audits) for the medical and
paramedical staff should be designed.
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of prematurity. Furthermore, an increasing risk of handicap has
been reported with an increasing number of fetuses (Luke and
Keith, 1992), and at least one handicapped child is found in 7.4,
21.6 and 50% of twin, triplet and quadruplet pregnancies, respect-
ively (Yokoyama et al., 1995). Cerebral palsy seems to occur
respectively 5–6 and 17–20 times more often in twin and triplet
pregnancies compared with singletons (Petterson et al., 1993;
Pharoah and Cooke, 1996; Tanbo and Abyholm, 1996). The
importance of avoiding multiple pregnancies cannot be overem-
phasized when considering these risks against a backdrop of
inadequate health-care facilities.
Nowadays, a policy of elective single embryo transfer (eSET) is
reported as the most efﬁcacious measure of reducing the incidence
of multiple pregnancies in ART (Wolner-Hanssen and Rydh-
stroem, 1998; Gerris et al., 1999, 2004; Van Royen et al., 1999;
Gerris, 2000; Tiitinen et al., 2001; De Sutter et al., 2002, 2003;
Gerris and Van Royen, 2005). In a large retrospective study, it
was shown that with the implementation of eSET multiple preg-
nancy delivery rates could drop from 25 to 5% (Tiitinen et al.,
2003). IUI in natural cycles and/or CC or letrozole-stimulated
cycles have a reported multiple pregnancy rate of ,8% which is
acceptable (Ombelet et al., 1996, 1997b). With the use of
human gonadotrophins (hMG) or recombinant FSH, IUI success
rates are signiﬁcantly higher but multiple pregnancy rates rise to
20–30% (Guzick et al., 1999).
Education and training
The implementation of new reproductive technologies will require
education and training. In the past physicians working in develop-
ing countries mostly covered the cost of their training in ART and
related procedures themselves, which also commonly included
expenditure associated with living abroad for prolonged periods
of time. This may account at least in part for the fact that many
of them subsequently seek to make their proﬁt in the private
sector (Inhorn, 2003). Training courses on semen analyses and
laparoscopic procedures have already been successfully conducted
in African countries (Serour and Hefnawi, 1982; Serour et al.,
1982; Franken et al., 2000a,b). Since 2005, efforts have intensiﬁed
under the auspices of the IFFS education programme, which facili-
tated workshops in many different countries such as Uruguay, the
Philippines and Nigeria.
Following training, quality control, regular audit and systems of
accreditation and registration should be implemented in order to
maintain appropriate standards of care.
The Arusha-project
December 2006, the Executive Committee of the European
Society of Human Reproduction and Embryology (ESHRE)
started with a new ‘Special Task Force’ dedicated to infertility
in developing countries. This Special Task Force aimed to encou-
rage more and affordable infertility diagnosis and treatment in
developing countries. December 2007, an expert meeting on the
topic of ‘Developing countries and infertility’ was organized in
Arusha, Tanzania. A summary of most Arusha presentations are
summarized in the ESHRE Monograph (July 2008). As a result
of this meeting, an action-plan and a road-plan to the future
have been outlined with the establishment of ﬁve Working-Groups
and ﬁve Study-Groups. Optimizing a concurrent and affordable
infertility diagnostic and treatment programme will be the most
important challenge. One of the Study-Groups will also deal
with health economics, quality-of-life and cost-effectiveness of
ART in resource-poor settings. One of the questions will be how
cost-effective fertility treatment will be in comparison with
other measures aimed to improve health. Whether we will not
create false expectations by introducing relatively expensive and
sophisticated fertility treatment will be another important subject
(http://www.eshre.com). Looking at the different strategies we
proposed, we still have to acknowledge that the question ‘would
the implementation of ART in developing countries result in
relief or grief’ should be discussed seriously all the way.
Funding and supporting the project of affordable
art in developing countries
Infertility programmes in developing countries can only be
implemented and sustained if they are supported by local policy
makers as well as the international community. A critical aspect
ofthis process is funding, and this is likely to require input and col-
laboration from various role players.
Governments
Expenditure on health as a percentage of gross domestic product
differs signiﬁcantly between different continents and different
countries (World Health Statistics, 2007). The American
(12.7%) and the European regions (8.6%) have the highest score
compared with the African (6%), the Western Paciﬁc (5.8%),
the Eastern Mediterranean (5.0%) and the South-East Asia
regions (4%). Evidently, these discrepancies translate into gross
inequalities with regard to global health care. From the perspective
of reproductive health, political statements and commitments need
to result in appropriate action in order to achieve ‘sexual and
reproductive health for all’ by 2015 as agreed to by 179 govern-
ments at the United Nations International Conference on Popu-
lation and Development in Cairo in 1994 (Fathalla et al., 2006).
More recently, health was recognized as one of the most import-
ant long-term foreign policy issues by the Ministers of Foreign
Affairs of Brazil, France, Indonesia, Norway, Senegal, South
Africa and Thailand. In a Ministerial declaration, the need for inte-
gration of health services was emphasized by stating that ‘The
well-functioning health systems that are needed to reduce maternal
newborn and child mortality and to combat HIV/AIDS, tubercu-
losis and malaria will also help countries to cope with other
major health concerns such as sexual and reproductive health
...’ (Oslo Ministerial Declaration, 2007).
There is consensus that stronger health systems, which are able
to deliver an integrated approach to health, are key elements to
achieve improved health outcomes (Van Zandvoort et al., 2001;
Travis et al., 2004). There are many reasons for fragile and
fragmented health services in developing countries, which include
political instability, poor quality governance, lack of work force,
inadequate drug supply and lack of functional information
systems. Research is urgently required on how to overcome these
barriers and strengthen health systems in resource-constrained
settings (Travis et al., 2004; Kumar, 2007).
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health in developing countries’
United Nations—World Health Organization
The World Health Organization is the United Nations specialized
agency for health. WHO’s objective is the attainment by all
peoples of the highest possible level of health. Health is deﬁned
in WHO’s Constitution as ‘a state of complete physical, mental
and social wellbeing and not merely the absence of disease or
inﬁrmity’.
WHO sponsored the largest study on the epidemiology of infer-
tility and has created a standardized approach to the diagnosis in
infertile couples (Cates et al., 1985; World Health Organization,
1987). At present, infertility prevention is the main objective of
WHO’s infertility-related reproductive health programme. At a
more recent meeting on ‘Medical, Ethical and Social Aspects of
Assisted Reproduction’ in 2001, WHO called for the integration
of infertility into existing sexual and reproductive health-care pro-
grammes and for highlighting the issue of ART in developing
countries. Table V summarizes part of the recommendations
agreed at the meeting (Vayena et al., 2002a). Progress towards
the attainment of these goals remains, however, slow. The
reasons for this are multiple and include, among others, the
problem of ‘brain drain’, lack of collaboration, budgetary con-
straints and lack of political commitment (Fathalla et al., 2006;
Kumar, 2007).
The population council
The Population Council (www.popcouncil.org) is an international,
non-proﬁt, non-governmental organization (NGO) that conducts
biomedical, social science and public health research. For more
than 50 years, the Council has been a leader in conducting
studies on a range of reproductive health issues. Council research
emphasizes the synergy of reproductive health and family plan-
ning services and seeks to combine them successfully and
cost-effectively. The Population Council conducts reproductive
health research in reducing unsafe abortion, prevention of STDs
and promoting and supporting safe motherhood and post-partum
care. Establishing fertility centres in developing countries are
not a priority.
Family Health International
Family Health International (FHI) (www.fhi.org) is a leader
among not-for-proﬁt international public health organizations,
managing research and ﬁeld activities in more than 70 countries
to meet the public health needs of some of the world’s most vul-
nerable people. This organization tries to help countries and com-
munities to prevent the spread of HIV/AIDS and STDs and care
for those affected by them, to improve people’s access to quality
reproductive health services, especially safe, effective and afford-
able family planning methods and to improve the health of women
and children, especially those who live in resource-constrained
settings. The implementation of ART in developing countries is
not a goal of this organization.
International Federation of Gynaecology and Obstetrics
The International Federation of Gynaecology and Obstetrics
(FIGO) (www.ﬁgo.org) brings together professional Societies of
obstetricians and gynaecologists of 113 countries. Its mission is
to promote the wellbeing of women and their children and to
raise the standard of practice in obstetrics and gynaecology
around the world. This organization strives to ensure respect for
women and advancement of their status.
FIGO commits its resources through educational, research and
advocacy activities to strengthen its links with and between its
member societies. FIGO initiatives in developing countries focus
on reducing perinatal and maternal morbidity and mortality. The
FIGO Committee for the Ethical Aspects of Human Reproduction
and Women’s Health elaborated on the ethical obligation in pre-
venting infertility and on ethical guidelines for ART practice to
minimize complications particularly in developing countries
(www.ﬁgo.org).
International Federation of Fertility Societies
TheInternationalFederationofFertilitySocieties(IFFS)wasbornin
1968. At present, 57 National Fertility Societies are afﬁliated. It is
estimated that over 40 000 fertility specialists worldwide are
brought together under one umbrella organization (www.iffs-
reproduction.org). The most important objectives of IFFS are to
stimulatebasicandappliedresearchandthedisseminationofknowl-
edge in all aspects of reproduction and fertility. The IFFS education
Table V. Report and Recommendations of the WHO-meeting on ‘Medical, Ethical and Social Aspects of Assisted Reproduction’, Geneva, 2001 (Vayena
et al., 2002a).
(1) Infertility should be recognized as a Public Health issue worldwide, including developing countries.
(2) Research is needed on innovative, low-cost ART procedures that provide safe, effective, acceptable and affordable treatment for infertility.
(3) Policy makers and health staff should give attention to infertility and the needs of infertile patients.
(4) Governments should improve education in infertility and reproductive health for the general public and health-care professionals.
(5) A gender perspective needs to be applied by healthcare providers to infertility management and treatment.
(6) Infertility management should be integrated into national reproductive health education programmes and services.
(7) Physicians should provide adequate investigation facilities and treatment for the infertile couple in a culturally sensitive and ethically acceptable manner.
(8) Where appropriate, traditional healers should be included in the dialogue between patients and health-care providers concerning the treatment of infertility.
(9) Where public funding is insufﬁcient, alternative sources of funding for public sector ART programmes should be sought.
(10) Cost-effective options, including the establishment of national networks of satellite clinics to screen and refer appropriate couples to specialist centres,
should be examined as a means of improving access to ART.
(11) ART should be complementary to other ethically acceptable, social and cultural solutions to infertility.
(12) Public awareness of infertility and its causes should be increased to improve preventative behaviour and to diminish the stigmatization and social exclusion
of infertile men and women.
(13) The dissemination of public information on the options for treatment of infertility, including adoption and the ethical and legal issues involved, should be
improved.
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in developing countries. This initiative, which is the ﬁrst of its kind,
was met with great enthusiasm by various developing countries
indicating the need for the advancement of infertility care.
The European Society for Human Reproduction and Embryology
The European Society of Human Reproduction and Embryology
(ESHRE) was ofﬁcially founded in Bonn (1985). The main aim
of ESHRE is to promote interest in, and understanding of repro-
ductive biology and medicine (www.eshre.com). It also aims to
promote improvements in clinical practice by organizing teaching,
training and continuing medical educational activities, developing
and maintaining data registries and implementing methods to
improve safety and quality assurance in clinical and laboratory
procedures.
In 2006, the executive committee of ESHRE agreed upon the
foundation of a new ‘Special Task Force (STF)’ on ‘Developing
countries and infertility’. This STF aims to document the problem
of infertility in developing countries, to develop and test the effec-
tiveness of a simpliﬁed ‘one-step clinic’ for the diagnosis of infer-
tility,todevelopandtesttheeffectivenessofsimpliﬁedIVF-related
procedures, to develop strategies for minimizing the risks of ART
and to promote the linkage of family planning, maternal and neo-
natal care and infertility treatment. The STF also aims to search
fortheoptimalmanagementstrategyforsubfertilecouplesindevel-
opingcountrieswithemphasisonnon-IVFtreatmentandother(sur-
gical or medical) options before starting IVF. Other plans for the
STF are to organize expert meetings and training courses for ferti-
lity specialists and paramedical staff from developing countries, to
approach the media and to work together with other non-proﬁt
organizations with common interests.
Patient support networks
From a political point of view, it is very important that patient
organizations claim the right to equitable access to infertility treat-
ment all over the world (Dill, 2007). The International Consumer
Support for Infertility (iCSi—www.icsi.ws) is a global family of
patient associations of 39 countries in all world regions. In sub-
Saharan Africa, the Joyce Fertility Support Centre Uganda was
founded in 1998 to bring forward the idea of providing a holistic
approach to the problem of infertility. Joyce Fertility Support is
breaking with tradition by openly talking about infertility, its
causes and its treatments. This patient network tries to convince
local people that infertility affects both men and women, and
that methods to prevent and to treat it are available (www.joyce-
fertility.org). Recently Joyce Fertility Support launched the
African Infertility Alliance which brings together the countries
of Uganda, Kenya, Zimbabwe and Israel to share issues concern-
ing infertility. Patients’ voices will be crucial when the issue of
infertility has to be discussed with policy makers.
The role of industry
It will be essential to convince industry of the value of infertility
treatment in developing countries and to gain their support for
Foundations and NGOs in this area of reproductive health. Apart
from general support, the industry can make several relevant con-
tributions. Providing cheap medication will be an important issue,
as will be the manufacturing of basic ultrasound and laboratory
equipment at low price. Industry has also become an important
source of funding for clinical research and this source should be
utilized in developing countries. As for all clinical research,
ethics committees and review bodies are needed for the appropri-
ate monitoring of studies (Abbas, 2007).
Ethical aspects of ‘infertility treatment
in developing countries’
The wish for a child is a basic need for all people. In developing
countries, childlessness has important psychological, social and
economic consequences as previously outlined. The question is
not whether fertility care is ethically justiﬁed in resource-poor
developing countries but whether we can propose the more wide-
spread use of ART as a valuable strategy. In our view, reproduc-
tive autonomy and equity justify our efforts to make ART
available and affordable worldwide subject to political stability
and a basic level of medical infrastructure. This does not mean
that fair access to scarce resources, non-maliﬁcence and treatment
effectiveness are not equally important, of course.
Even if we succeed in implementing low-cost IVF, it remains
however unlikely that treatment will become universally accessi-
ble. We may speculate that those who can afford treatment in
low-resource settings are also able to raise a child in reasonable
circumstances. In contrast, men and women living in extreme
poverty cannot and should not access infertility treatment but
require socio-political interventions, which improve their econ-
omical situation.
Another controversial question is whether infertility treatment
should be offered to HIV positive couples in countries with a
high HIV-related mortality and morbidity. While the answer to
this question is likely to centre on the availability of antiretroviral
medication, all HIV-infected couples require in-depth counselling
on the pregnancy-related risks as well as on different reproductive
choices, including, where indicated and accessible, ART. Unilat-
eral promotion of contraception contradicts the concept of repro-
ductive autonomy (Myer et al., 2005; Delvaux and No ¨stlinger,
2007).
Economic aspects of ‘infertility care
in developing countries’
A cost-beneﬁt analysis of simpliﬁed and affordable ART in devel-
oping countries does not exist and the subject is extremely difﬁcult
to study (Ombelet and Campo, 2007). The results will depend
largely on the cost of the diagnostic procedures and the ART treat-
ment itself. Pilot studies are urgently needed to examine the
precise cost of ART when the laboratory environment and equip-
ment are available at minimal cost and when minimal stimulation
protocols with cheap medication and minimal monitoring are
used. The economic value of a newborn in developing countries
has never been studied and will likely depend on the economic
and demographic situations.
Conclusion
Infertility is a common reproductive health problem in developing
countries, which frequently carries negative psychosocial impli-
cations. In many instances, infertility is caused by genital tract
Ombelet et al.
616infections. This highlights the need for both preventative health
care measures and ART. New reproductive technologies can
only be successfully introduced in developing countries if socio-
cultural and economic prerequisites are fulﬁlled and governments
can be persuaded to support their introduction. We have to liaise
with the relevant authorities to discuss the strengthening of infer-
tility services, at the core of which lies the integration of infertility,
contraceptive and maternal health services within public health-
care structures. Beyond this, the success and sustainability of
ART in resource-low settings will depend to a large extend on
our ability to optimize these techniques in terms of availability,
affordability and effectiveness. It is our duty to give correct infor-
mation to the governments, health-care providers and infertile
couples to avoid the situationwhere couples would sacriﬁce every-
thing they have or could borrow, for low-quality low success IVF.
After a fascinating period of almost 30 years of IVF and 15
years of ICSI, only a small part of the world population beneﬁts
from these new technologies. Time has come to give adequate
attention to the issue of infertility in developing countries.
Funding
Funding to pay the Open Access publication charges for this
article was provided by GIFT NPO.
References
Abbas EE. Industry-sponsored research in developing countries. Contemp Clin
Trials 2007;28:677–683.
Aboulghar MA. The importance of fertility treatment in the developing world.
BJOG 2005;112:1174–1176.
Adeniji RA, Olayemi O, Okunlola MA, Aimakhu CO. Pattern of semen
analysis of male partners of infertile couples at the University College
Hospital, Ibadan. West Afr J Med 2003;22:243–245.
Adetoro OO, Ebomoyi EW. The prevalence of infertility in a rural Nigerian
community. Afr J Med Sci 1991;20:23–27.
Adler MW. Sexually transmitted diseases control in developing countries.
Genitourin Med 1996;72:83–88.
Araoye MO. Epidemiology of Infertility: social problems of the infertile
couple. West Afr J Med 2003;22:190–196.
Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and
clomiphene citrate in women with polycystic ovaries undergoing ovarian
stimulation. J Int Med Res 2006;34:73–76.
Bambra CS. Current status of reproductive behaviour in Africa. Hum Reprod
Update 1999;5:1–20.
Barten J. Screening for infertility in Indonesia. Results of examination of 863
infertile couples. Andrologia 1978;10:405–412.
Bauer M, Chytilova J, Streblov P. Effects of Education on determinants of high
desired fertility: Evidence from Ugandan Villages. Charles University,
2006. IES Working Paper 239/2006, IES FSV. http://ies.fsv.cuni.cz.
Begum MR, Quadir E, Begum A, Begum RA, Begum M. Role of aromatase
inhibitor in ovulation induction in patients with poor response to
clomiphene citrate. J Obstet Gynaecol Res 2006;32:502–506.
Bergstrom S. Reproductive failure as a health priority in the Third World: a
review. East Afr Med J 1992;69:174–180.
Bharadwaj A. Why adoption is not an option in India: the visibility of
infertility, the secrecy of donor insemination, and other cultural
complexities. Soc Sci Med 2003;56:1867–1880.
Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of
infertility prevalence and treatment-seeking: potential need and demand
for infertility medical care. Hum Reprod 2007;22:1506–1512.
Brocklehurst P, French R. The association between maternal HIV infection and
perinatal outcome: a systematic review of the literature and meta-analysis.
Br J Obstet Gynaecol 1998;105:836–848.
Brosens I, Campo R, Puttemans P, Gordts S. One-stop endoscopy-based
infertility clinic. Curr Opin Obstet Gynecol 2002;14:397–400.
Campo R, Van Belle Y, Rombauts L, Mestdagh G, Lauwers M, Braekmans P,
Brosens I, Van Belle Y, Gordts S. Ofﬁce mini-hysteroscopy. Hum Reprod
Update 1999;5:73–81.
Campo R, Molinas CR, Rombauts L, Mestdagh G, Lauwers M, Braekmans P,
Brosens I, Van Belle Y, Gordts S. Prospective multicentre randomized
controlled trial to evaluate factors inﬂuencing the success rate of ofﬁce
diagnostic hysteroscopy. Hum Reprod 2005;20:258–263.
Casper RF. Aromatase inhibitors in ovarian stimulation. Steroid Biochem Mol
Biol 2007;106:71–75.
Cates W, Farley TM, Rowe PJ. Worldwide patterns of infertility: is Africa
different? Lancet 1985;2:596–598.
Chigumadzi PT, Moodley J, Bagratee J. Infertility proﬁle at King Edward VIII
Hospital, Durban, South Africa. Trop Doct 1998;28:168–172.
Cohen J. Associated multiple gestation–ART. Clin Obstet Gynecol
2003;46:363–374.
Daar AS, Merali Z. Infertility and social suffering: the case of ART in
developing countries. In: Vayena E, Rowe PJ, Grifﬁn PD (eds). Current
Practices and Controversies in Assisted Reproduction. Geneva,
Switzerland: World Health Organization, 2002,15–21.
Davis G, Ellis J, Hibbert M, Perez RP, Zimbleman E. Female circumcision: the
prevalence and nature of the ritual in Eritrea. Mil Med 1999;164:11–16.
Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA, YoungLai EV. Natural
cycles for in-vitro fertilization: cost-effectiviness analysis and factors
inﬂuencing outcome. Hum Reprod 1995;10:1719–1724.
De Jonge ETM, Hartman CR, Swaenepoel HM, Pistorius LR, Ombelet W.
Hysterosalping-contrast-sonography as a triage for tubal patency in a
population at risk for pelvic infection. Middle East Fertil Soc J
2001;6:239–244.
Delvaux T, No ¨stlinger C. Reproductive Choice for women and men living with
HIV, contraception, abortion and fertility. Reprod Health Matters
2007;15(Suppl. 29):46–66.
De Muylder X. Role of hysterosalpingography in the evaluation of infertility in
Black Africa. Med Trop (Mars) 1995;55:160–164.
De Sutter P, Gerris J, Dhont M. A health-economic decision-analytic model
comparing double with single embryo transfer in IFV/ICSI. Hum
Reprod 2002;17:2891–2896.
De Sutter P, Van der Elst J, Coetsier T, Dhont M. Single embryo transfer and
multiplepregnancyrate reduction in IVF/ICSI: a 5-year appraisal. Reprod
Biomed Online 2003;6:464–469.
Dill SK. International treatment differences: Policy, politics, partnership and
ART. Pharm Policy Law 2007;9:147–156.
Dyer SJ. The value of children in African countries: insights from studies on
infertility. J Psychosom Obstet Gynaecol 2007;28:69–77.
Dyer SJ, Abrahams N, Hoffman M, van der Spuy ZM. ‘Men leave me as I
cannot have children’: women’s experiences with involuntary
childlessness. Hum Reprod 2002a;17:1663–1668.
Dyer SJ, Abrahams N, Hoffman M, van der Spuy ZM. Infertility in South
Africa: women’s reproductive health knowledge and treatment-seeking
behaviour for involuntary childlessness. Hum Reprod 2002b;17:
1657–1662.
Dyer SJ, Abrahams N, MokoenaNE, van der Spuy ZM.“you are a manbecause
you have children”: experiences, reproductive health knowledge and
treatment-seeking behaviour among men suffering from couple
infertility in South Africa. Hum Reprod 2004;19:960–967.
Dyer SJ, Abrahams N, Mokoena NE, Lombard CJ, van der Spuy ZM.
Psychological distress among women suffering from couple infertility in
South Africa: a quantitative assessment. Hum Reprod 2005;20:
1938–1943.
Ebomoyi E, Adetoro OO. Socio-biological factors inﬂuencing infertility in
a rural Nigerian community. Int J Gynaecol Obstet 1990;33:41–47.
El-Beheiry A, Abou-Zeid S, El-Ghazzawi E, El-Mansy E, Salama N. The
leprous testis. Arch Androl 1979;3:173–176.
Elster N. Less is more: the risks of multiple births. Fertil Steril 2000;74:
617–623.
The ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum
Reprod 2000;15:1856–1864.
Ericksen K, Brunette T. Patterns and predictors of infertility among African
women: a cross-national survey of twenty-seven nations. Soc Sci Med
1996;42:209–220.
Fathalla MF. Reproductive health: a global overview. Early Hum Dev
1992;29:35–42.
Fathalla MF. Current challenges in assisted reproduction. In: Vayena E, Rowe
PJ, Grifﬁn PD (eds). Current Practices and Controversies in Assisted
Reproduction. Geneva, Switzerland: World Health Organization,
2002,3–12.
Developing countries and infertility
617Fathalla MF, Sinding SW, Rosenﬁeld A, Fathalla MMF. Sexual and
reproductive health for all: a call for action. Lancet 2006;368:2095–2100.
Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B.
Efﬁcacy of low-dose human chorionic gonadotropin alone to complete
controlled ovarian stimulation. Fertil Steril 2005a;84:394–401.
Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao ChV, Tesarik J, Zygmunt
M. Novel conceptsof humanchorionicgonadotropin: reproductive system
interactions and potential in the management of infertility. Fertil Steril
2005b;84:275–284.
Franken DR, Barendsen R, Kruger TF. A continuous quality control program
for strict sperm morphology. Fertil Steril 2000a;74:724–724.
Franken DR, Smith M, Menkveld R, Kruger TF, Sekadde-Kigondu C, Mbizvo
M, Akande EO. The development of a continuous quality control
programme for strict sperm morphology among sub-Saharan African
laboratories. Hum Reprod 2000b;15:667–671.
Geelhoed DW, Nayembil D, Asare K, Schagen van Leeuwen JH, Roosmalen J.
Infertility in rural Ghana. Int J Gynaecol Obstet 2002;79:137–142.
Gerais AS, Rushwan H. Infertility in Africa. Popul Sci 1992;12:25–46.
Gerris JM. Single embryo transfer and IVF/ICSI outcome: a balanced
appraisal. Hum Reprod Update 2005;11:105–121.
Gerris J, De Neubourg D, Mangelschots K, Van Royen E, Van de Meerssche
M, Valkenburg M. Prevention of twin pregnancy after in-vitro fertilization
or intracytoplasmic sperm injection based on strict embryo criteria: a
prospective randomized clinical trial. Hum Reprod 1999;14:2581–2587.
GerrisJ, VanRoyen E.Avoidingmultiplepregnanciesin ART:a pleafor single
embryo transfer. Hum Reprod 2000;15:1884–1888.
Gerris J, De Sutter P, De Neubourg D, Van Royen E, Vander Elst J,
Mangelschots K, Vercruyssen M, Kok P, Elseviers M, Annemans L
et al. A real-life prospective health economic study of elective single
embryo transfer versus two-embryo transfer in ﬁrst IVF/ICSI cycles.
Hum Reprod 2004;19:917–923.
Gerrits T. Social and cultural aspects of infertility in Mozambique. Patient
Educ Counsel 1997;31:39–48.
Gilling-Smith C, Nicopoullos JD, Semprini AE, Frodsham LC. HIV and
reproductive care – a review of current practice. BJOG 2006;113:
869–878.
Giwa-Osagie OF. ART in developing countries with particular reference to
sub-Saharan Africa. In: Vayena E, Rowe PJ, Grifﬁn PD (eds). Current
Practices and Controversies in Assisted Reproduction. Geneva,
Switzerland: World Health Organization, 2002a,22–27.
Giwa-Osagie OF. Social and ethical aspects of assisted conception an
Anglophone sub-Saharan Africa. In: Vayena E, Rowe PJ, Grifﬁn PD
(eds). Current Practices and Controversies in Assisted Reproduction.
Geneva, Switzerland: World Health Organization, 2002b,50–54.
Giwa-Osagie OF. Managementof infertilityand ethicalissues:currenttrendsin
sub-saharan Africa. In: Sekadde-Kigondu C, Chikamata D, Franken D
(eds). Management of Infertility in AFRO & EMRO Countries. Geneva,
Switzerland: World Health Organization Proceedings of a Workshop,
2002c,117–132.
Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk
of high-order multiple pregnancy after ovarian stimulation with
gonadotropins. N Engl J Med 2000;343:2–7.
Glynn JR, Buve ´ A, Carae ¨l M, Kahindo M, Macauley IB, Musonda RM,
Jungmann E, Tembo F, Zekeng L. Decreased fertility among
HIV-1-infected women attending antenatal clinics in three African
cities. J Acquir Immune Deﬁc Syndr 2000;25:345–352.
Gnoth C, Frank-Herrmann P, Freundl G. Opinion: natural family planning and
the management of infertility. Arch Gynecol Obstet 2002;267:67–71.
Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to
pregnancy: results of the German prospective study and impact on the
management of infertility. Hum Reprod 2003;18:1959–1966.
Gordts S, Campo R, Rombauts L, Brosens I. Transvaginal hydrolaparocopy as
an outpatient procedure for infertility investigation. Hum Reprod
1998;13:99–103.
Gordts S, Campo R, Puttemans P, Verhoeven H, Gianaroli L, Brosens
J, Brosens I. Investigation of the infertile couple: a one-stop outpatient
endoscopy-based approach. Hum Reprod 2002;17:1684–1687.
Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J.
Intrauterine insemination or in-vitro fertilisation in idiopatic subfertility
and male subfertility: a randomised trial and cost-effectiveness analysis.
Lancet 2000;355:13–18.
Grimes DA, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, Shah IH.
Unsafe abortion: the preventable pandemic. Lancet 2006;368:1908–1919.
Guilhem D. New reproductive technologies, ethics and legislation in Brazil: a
delayed debate. Bioethics 2001;15:218–230.
Gunalp S, Onculoglu C, Gurgan T, Kruger TF,Lombard CJL. A study of semen
parameters with emphasis on sperm morphology in a fertile population: an
attempt to develop clinical thresholds. Hum Reprod 2001;16:110–114.
Guzick DS. Ovulation induction management of PCOS. Clin Obstet Gynecol
2007;50:255–267.
Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P,
Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST et al.
Efﬁcacy of superovulation and intrauterine insemination in the
treatment of infertility. National Cooperative Reproductive Medicine
network. N Engl J Med 1999;340:177–183.
Haile A. Fertility conditions in Gondar, northwestern Ethiopia: an appraisal of
current status. Stud Fam Plann 1990;21:110–118.
Hamberger L, Janson PO. Global importance of infertility and its treatment:
role of fertility technologies. Int J Gynaecol Obstet 1997;58:149–158.
Handwerker L. Social and ethical implications of in vitro fertilization in
contemporary China. Camb Q Healthc Ethics 1995;4:355–363.
Handwerker L. The politics of making modern babies in China. In: horn
MC, van Balen F (eds). Infertility Around the Globe. London:
University of California Press, 2002, 298–314.
Hauge K, Flo K, Riedhart M, Granberg S. Can ultrasound-based investigations
replace laparoscopy and hysteroscopy in infertility? Eur J Obstet Gynecol
Reprod Biol 2000;92:167–170.
Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER,
Broekmans FJ, Passchier J, te velde ER, Macklon NS et al. A mild
treatment strategy for in-vitro fertilisation: a randomised non-inferiority
trial. Lancet 2007;369:
743–749.
Henshaw SK, Singh S, Haas T. The incidence of abortion worldwide. Int Fam
Plann Persp 1999;25:S30–S38.
Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two
ovarian stimulation protocols with gonadotropin-releasing hormone
(GnRH) antagonist cotreatment for in vitro fertilization commencing
recombinant follicle-stimulating hormone on cycle day 2 or 5 with the
standard long GnRH agonist protocol. J Clin Endocrinol Metab
2003;88:166–173.
Hollos M. Proﬁles of infertility in southern Nigeria: womens’s voices from
Amakiri. Afr J Reprod Health 2003;7:46–56.
HovattaO, Cooke I. Cost-effective approachesto in vitro fertilization: means to
improve access. Int J Gynaecol Obstet. 2006;94:287–291.
Huyser C, Loskutoff NM, Singh R, Webber L, Franken DR. Enhanced sperm
quality using advanced density gradient technology. Hum Reprod
2006;21(Suppl. 1):i58.
Ikechebelu JI, Adinma JI, Orie EF, Ikegwuonu SO. High prevalence of male
infertility in southeastern Nigeria. J Obstet Gynaecol 2003;23:657–659.
Ingerslev HJ, Hojgaard A, Hindkjaer J, Kesmodel U. A randomized study
comparing IVF in the unstimulated cycle with IVF following
clomiphene citrate. Hum Reprod 2001;16:696–702.
Inhorn MC. Global infertility and the globalization of new reproductive
technologies: illustrations from Egypt. Soc Sci Med 2003;56:1837–1851.
Kafy S, Tulandi T. New advances in ovulation induction. Curr Opin Obstet
Gynecol 2007;19:248–252.
Kiguli-Malwadde E, Byanyima RK. Structural ﬁndings at
hysterosalpingography in patients with infertility at two private clinics
in Kampala, Uganda. Afr Health Sc 2004;4:178–181.
Kahn SM. Rabbis and reproduction – the use of new reproductive technologies
among ultraorthodox jews in Israe ¨l. In: Inhorn MC, van Balen F (eds).
Infertility Around the Globe. London: University of California Press,
2002,283–297.
Kiros K. The prevention and management of infertility – WHO/AFRO strategy.
In: Sekadde-Kigondu C, Chikamata D, Franken D (eds). Management of
infertility in AFRO & EMRO countries. Geneva, Switzerland: World
Health Organization Proceedings of a workshop, 2002,92–98.
Kuku SF, Osegbe ND. Oligo/azoospermia in Nigeria. Arch Androl
1989;22:233–237.
Kumar P. Providing the providers – Remedying Africa’s shortage of Health
Care Workers. N Engl J Med 2007;356:2564–2567.
Larsen U. Childlesssness, subfertility, and infertility in Tanzania. Stud Fam
Plann 1996;27:18–28.
Larsen U. Primary and secondary infertility in sub-Saharan Africa. Int J
Epidem 2000;29:285–291.
Leke RJ. The prevalence of infertility and its preventive measures in
Sub-Saharan Africa. In: Sekadde-Kigondu C, Chikamata D, Franken D
(eds). Management of Infertility in AFRO & EMRO Countries. Geneva,
Switzerland: World Health Organization Proceedings of a workshop,
2002,79–91.
Ombelet et al.
618Leke RJ, Oduma JA, Bassol-Mayagoitia S, Bacha AM, Grigor KM. Regional
and geographical variations in infertility: effects on environmental,
cultural, and socioeconomic factors. Environ Health Perspect
1993;101(Suppl. 2):73–80.
Leke RJ, Busingye R, Kiros K, Tozin RR, Oyieke BO, Chikamata D.
Prevention of infertility. In: Sekadde-Kigondu C, Chikamata D, Franken
D (eds). Management of Infertility in AFRO & EMRO Countries.
Geneva, Switzerland: World Health Organization Proceedings of a
workshop, 2002,43–48.
Leonard L. “Looking for Children”: the search for fertility among the Sara of
southersn Chad. Med Anthropol 2002;21:79–112.
LoskutoffNM, Huyser C, Singh R, WalkerDL, Thornhill AR, MorrisL,Webber
L.Useofanovelwashingmethodcombiningmultipledensitygradientsand
trypsinforremovinghumanimmunodeﬁciencyvirus-1andhepatitisCvirus
from semen. Fertil Steril 2005;84:1001–1010.
Luke B, Keith LG. The contribution of singletons, twins and triplets to low
birth weight, infant mortality and handicap in the United States.
J Reprod Med 1992;37:661–666.
Luna F. Assisted reproductive technology in Latin America: some ethical and
sociocultural issues. In: Vayena E, Rowe PJ, Grifﬁn PD (eds). Current
Practices and Controversies in Assisted Reproduction. Geneva,
Switzerland: World Health Organization, 2002,31–40.
Lyerly AD, Anderson J. Human immunodeﬁciency virus and assisted
reproduction: reconsidering evidence, reframing ethics. Fertil Steril
2001;75:843–858.
Makush M, Botega N, Bahamondes L. Physician-patient communication in the
prevention of female reproductive tract infections: some limitations.
Cadern S Publ 2000;16:249–253.
MalpaniA,MalpaniA.Simplifyingassistedconceptiontechniquestomakethem
universally available–a view from India. Hum Reprod 1992;7:49–50.
Mascie-Taylor CG. Endemic disease, nutrition and fertility in developing
countries. J Biosoc Sci 1992;24:355–365.
Massey JB, Ingargiola PE, Tucker MJ, Mitchell-Leef DE, Wright G. Minimal
stimulation with simpliﬁed monitoring for in vitro fertilization. J Assist
Reprod Genet 1994;11:353–358.
Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, Senkoro
K, Rusizoka M, Laga M, Hayes R et al. Risk assessment and other
screening options for gonorrhoea and chlamydial infections in women
attending rural Tanzanian antenatal clinics. Bull World Health Organ.
1995;73:621–630.
MeheusA, Reniers J, Colletet M. Determinants of infertilityin Africa. Afr J Sex
Transmi Dis 1986;2:31–35.
Menkveld R, Wong WY, Lombard CJ, Wetzels AMM, Thomas CMG, Merkus
HMWM, Steegers-Theunissen PM. Semen parameters, including WHO
and strict criteria morphology, in a fertile and subfertile population: an
effort towards standardization of in-vivo thresholds. Hum Reprod
2001;16:1165–1171.
Myer L, Morroni C, Nachega J, Cooper D. HIV-infected women in ART
programmes. Lancet 2005;365:655–656.
Nabaitu J, Bachengana C, Seeley J. Marital instability in a rural population in
south-west Uganda: implications for the spread of HIV-1 infection. Africa
(Lond) 1994;64:243–251.
Nachtigall RD. International disparities in access to infertility services. Fertil
Steril 2006;85:871–875.
Nargund G, Waterstone J, Bland JM, Philips Z, Parsons J, Campbell S.
Cumulated conception and live birth rates in natural (unstimulated) IVF
cycles. Hum Reprod 2001;16:259–262.
Obermeyer CM. The consequences of female circumcision for health and
sexuality: an update on the evidence. Cult Health Sex 2005;7:443–461.
OkumuCV, Kamau RK, Rogo KO. Pastreproductiveand sexual characteristics
of women with tubal infertility at Kenyatta National Hospital. East Afr
Med J 1990;67:864–872.
Okonofua FE. The case against new reproductive technologies in developing
countries. Br J Obstet Gynaec 1996;103:957–962.
Okonofua FE, Esen UI, Nimalaraj T. Hysterosalpingography versus
laparoscopy in tubal infertility: comparison based on ﬁndings at
laparotomy. Int J Gynecol Obstet 1989;28:143–147.
Okonofua FE, Ako-Nai KA, Dighitoghi MD. Lower genital tract infections in
infertile Nigerian women compared to controls. Genitourin Med
1995;71:163–168.
Olantunji AO, Sule-Odu AO. The pattern of infertility cases at a university
hospital. West Afr J Med 2003;22:205–207.
Ombelet W, Campo R. Affordable IVF for developing countries. Reprod
Biomed Online 2007;15:267–265.
Ombelet W, Puttemans P, Brosens I. Intrauterine insemination: a ﬁrst-step
procedure in the algorithm of male subfertility treatment. Hum Reprod
1995;10(Suppl. 1):90–102.
Ombelet W, Cox A, Janssen M, Vandeput H, Bosmans E. Artiﬁcial
insemination: using the husband’s sperm. In: Acosta AA, Kruger TF
(eds). Diagnosis and Therapy of Male Factor In Assisted Reproduction.
New York: Parthenon Publishing, 1996,397–410.
Ombelet W, Bosmans E, Janssen M, Cox A, Vlasselaer J, Gyselaers W,
Vandeput H, Gielen J, Pollet H, Maes M et al. Semen parameters in a
fertile versus subfertile population: a need for change in the
interpretation of semen testing. Hum Reprod 1997a;12:987–993.
Ombelet W, Vandeput H, Van de Putte G, Cox A, Janssen M, Jacobs P,
Bosmans E, Kruger T. Intrauterine insemination after ovarian
stimulation with clomiphene citrate: predictive potential of inseminating
motile count and sperm morphology. Hum Reprod 1997b;12:
1458–1463.
Ombelet W, Pollet H, Cox A, Janssen M, Vandeput H, Bosmans E. Male
fertility assessment: Microscopic examination versus biochemical
parameters. In: Ombelet W, Stevens K, Vandeput H, Vereecken
A, Bosmans E (eds). Book of Abstracts and Miniposters. Genk:
Andrology in the Nineties, 1998,26.
Ombelet W, Deblaere K, Bosmans E, Cox A, Jacobs P, Janssen M, Nijs M.
Semen quality and intrauterine insemination. Reprod Biomed Online
2003;7:485–492.
Ombelet W, De Sutter P, Van der Elst J, Martens G. Multiple gestation and
infertility treatment: registration, reﬂection and reaction: the Belgian
project. Hum Reprod Update 2005;11:3–14.
Orji EO, Kuti O, Fasubaa OB. Impact of infertilityon marital life in Nigeria. Int
J Gynaecol Obstet 2002;79:61–62.
Oslo Ministerial Declaration–global health: a pressing foreign policy issue of
our time. Lancet 2007;369:1373–1378.
Otolorin EO, Ojengbede O, Falase AO. Laparoscopic evaluation of the
tuboperitoneal factor in infertile Nigerian women. Int J Gynaecol Obstet
1987;25:47–51.
Otubu JA, Sagay AS, Dauda S. Hysterosalpingogram, laparoscopy and
hysteroscopy in the assessment of the infertile Nigerian women. East
Afr Med J 1990;67:370–374.
Papreen N, Sharma A, Sabin K, Begum L, Ahsan SK, Baqui AH. Living with
infertility: experiences among Urban slum populations in Bangladesh.
Reprod Health Matters 2000;8:33–44.
Parikh FR, Nadkami SG, Kamat SA, Naik N, Soonawala SB, Parikh RM.
Genital tuberculosis–a major pelvic factor causing infertility in Indian
women. Fertil Steril 1997;67:497–500.
Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efﬁcacy of natural cycle IVF:
a review of the literature. Hum Reprod Update 2002;8:129–139.
Pelinck MJ, Vogel NE, Hoek A, Simons AH, Arts EG, Mochtar MH,
Beemsterboer S, Hondelink MN, Heineman MJ. Cumulative pregnancy
rates after three cycles of minimal stimulation IVF and results
according to subfertility diagnosis: a multicentre cohort study. Hum
Reprod 2006;21:2375–2383.
Peterson CM, Hatasaka HH, Jones KP, Poulson AM, Jr, Carrell DT, Urry RL.
Ovulation induction with gonadotropins and intrauterine insemination
compared with in vitro fertilization and no therapy: a prospective,
nonrandomized, cohort study and meta-analysis. Fertil Steril 1994;62:
535–544.
Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral
palsy in births in Western Australia in the 1980s. Br Med J
1993;307:1239–1243.
Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal
Neonatal Ed 1996;75:174–177.
Philips SJ, Kadoch IJ. Natural cycle IVF: a question of semantics? Reprod
Biomed Online 2007;15:255–256.
Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative
cost-effectiveness of treatments for infertility in the UK. Hum Reprod
2000;15:95–106.
Pilcher H. Fertility on a shoestring. Nature 2006;442:975–977.
Potts D, Marks S. Fertility in Southern Africa: the quiet revolution. J South Afr
Stud 2001;27:189–205.
Qiu R-Z. Sociocultural dimensions of infertility and assisted reproduction
in the Far East. In: Vayena E, Rowe PJ, Grifﬁn PD (eds). Current
Practices and Controversies in Assisted Reproduction. Geneva,
Switzerland: World Health Organization, 2002,75–80.
RanouxC, SeibelMM.New techniques in fertilization:intravaginalculture and
microvolume straw. J In Vitro Fert Embryo Transf 1990;7:6–8.
Developing countries and infertility
619Ranoux C, Dubuisson JB, Foulot H, Aubriot FX. Intravaginal culture and
embryo transfer. A new method for the fertilization of human oocytes.
Rev Fr Gynecol Obstet 1987;82:741–744.
Ranoux C, Aubriot FX, Dubuisson JB, Cardone V, Foulot H, Poirot
C, Chevallier O. A new in vitro fertilization technique: intravaginal
culture. Fertil Steril 1988;49:654–657.
Richards SC. “Spoiling the womb”: deﬁnitions, aetiologies and responses to
infertility in north west province, Cameroon. Afr J Reprod Health
2002;6:84–94.
Riessman CR. Stigma and everyday resistance practices: childless women in
South India. Gend Soc 2000;14:111–135.
Rojanasakul A, Choktanasiri W, Suchartwatanachai C, Srisombut C,
Chinsomboon S, Chatasingh S. ‘Simpliﬁed IVF’: program for
developing countries. J Med Assoc Thai 1994;77:12–18.
Sallam HN. Infertility in developing countries: funding the project. Hum
Reprod ESHRE Monograph 2008;5:97–101.
Saporta L, Yuksel A. Androgenic status in patients with lepromatous leprosy.
Br J Urol 1994;74:221–224.
Schenker JG. Women’s reproductive health: monotheistic religious
perspectives. Int J Gynaecol Obstet 2000;70:77–86.
Schenker JG. Assisted reproductive practice: religious perspectives. Reprod
Biomed Online 2005;10:310–319.
Sciarra JJ. Infertility:a globalperspective. The role of pelvic infection. ORGYN
1994;3:12–15.
Sciarra JJ. Sexually transmitted deseases: global importance. Int J Gynaecol
Obstet 1997;58:107–119.
Sekadde-Kigondu C, Machoki MJ. Workshop report on management of
infertility in Africa and eastern mediterranean regions. In:
Sekadde-Kigondu C, Chikamata D, Franken D (eds). Management of
Infertility in AFRO & EMRO Countries. Geneva, Switzerland: World
Health Organization Proceedings of a workshop, 2002,24–26.
Sekadde-Kigondu C, Chikamata D, Franken D. Management of Infertility in
AFRO & EMRO Countries. Geneva, Switzerland: World Health
Organization Proceedings of a workshop, 2002.
Serour GI. Ethical considerations of assisted reproductive technologies: a
middle eastern perspective. Middle East Fertil Steril J 2000;5:13–18.
Serour GI. Attitudes and cultural perspectives on infertility and its alleviation
in the middle East area. In: Vayena E, Rowe PJ, Grifﬁn PD (eds).
Current Practices and Controversies in Assisted Reproduction. Geneva,
Switzerland: World Health Organization, 2002,41–49.
SerourGI.Religiousperspectives ofethical issuesinART.Inethical dilemmas.
In assisted reproduction. In: Francoise S, Claude S (eds). 3rd edn. UK:
Informa Health Care, 2006,99–114.
Serour GI, Hefnawi FI. Diagnostic laparoscopy for infertile patients as a
training program. Int J Gynaecol Obstet 1982;20:19–22.
Serour GI, Kandil O, Askalani H, Younis N, Hefnawi F. Laparoscopy on
patients with previous lower abdominal surgery: a new technique. Int J
Gynaecol Obstet 1982;20:357–361.
Serour GI, El Ghar M, Mansour RT. Infertility: a health problem in the Muslim
world. Popul Sci 1991;10:41–58.
Shaheen R, Subhan F, Tahir F. Epidemiology of genital tuberculosis in infertile
population. J Pak Med Assoc 2006;56:306–309.
Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation
induction. Reprod Biomed Online 2002;4:303–310.
Stanton C, Blanc AK, Croft T, Choi Y. Skilled care at birth in the developing
world: progress to date and strategies expanding coverage. B Biosoc Sci
2007;39:109–120.
Steinkampf MP, Kretzer PA, McElroy E, Conway-Myers BA. A
simpliﬁed approach to in vitro fertilization. J Reprod Med 1992;37:
199–204.
Strandell DS, Lindhard A, Eckerlund I. Cost–effectiveness analysis of
salpingectomy prior to IVF, based on a randomized controlled trial.
Hum Reprod 2005;20:3284–3292.
Sundby J. Infertility in the Gambia: traditional and modern health care.
Patient Educ Counsel 1997;31:29–37.
Sundby J, Mboge R, Sonko S. Infertility in the Gambia: frequency and health
care seeking. Soc Sci Med 1998;46:891–899.
Tanbo T, Abyholm T. Obstetric and perinatal outcome in pregnancies after
assisted reproduction. Curr Opin Obstet Gynecol 1996;8:193–198.
Tangwa GB. ART and African sociocultural practices: worldview, belief and
value systems with particular reference to francophone Africa. In:
Vayena E, Rowe PJ, Grifﬁn PD (eds). Current Practices and
Controversies in Assisted Reproduction. Geneva, Switzerland: World
Health Organization, 2002,55–59.
Temmerman M. Sexually transmitted diseases and reproductive health. Sex
Transm Dis 1994;21:S55–S58.
Taymor ML, Ranoux CJ, Gross GI. Natural oocyte retrieval with intravaginal
fertilization: a simpliﬁed approach to in vitro fertilization. Obstet Gynecol
1992;80:888–891.
Tiitinen A, Halttunen M, Ha ¨rkki P, Vuoristo P, Hyden-Granskog C. Elective
single embryo transfer: the value of cryopreservation. Hum Reprod
2001;16:1140–1144.
Tiitinen A, Unkila-Kallio L, Halttunen M, Hyden-Granskog C. Impact of
elective single embryo transfer on the twin pregnancy rate. Hum Reprod
2003;18:1449–1453.
Travis P, Bennett S, Haines A, Pang T, Bhutta Z, Hyder AA, Pielemeier NR
et al. Overcoming health-systems constraints to achieve the Millennium
Development Goals. Lancet 2004;364:900–906.
Umezulike AC, Efetie ER. The psychological trauma of infertility in Nigeria.
Int J Gynaecol Obstet 2004;84:178–180.
Unisa S. Childlessness in Andhra Pradesh, India: treatment-seeking and
consequences. Reprod Health Matters 1999;7:54–64.
United Nations, Department of Economic and Social Affairs, population
Division. World Population Prospects: The 2006 Revision, Highlights,
2007. Working Paper No ESA/P/WP.202.
Vajta G, Holm P, Greve T, Callesen H. The submarine incubation system, a
new tool for in vitro embryo culture: a technique report. Theriogenology
1997;48:1379–1385.
Vajta G, Bartels P, Joubert J, de la Rey M, Treadwell R, Callesen H. Production
of a healthy calf by somatic cell nuclear transfer without
micromanipulators and carbon dioxide incubators using the Handmade
Cloning (HMC) and the Submarine Incubation System (SIS).
Theriogenology 2004;62:1465–1472.
Van Balen F. The psychologization of Infertility. In: Inhorn MC, van Balen F
(eds). Infertility Around the Globe. London: University of California
Press, 2002. 79–98.
Van Balen F, Gerrits T. Quality of infertility care in poor-resource areas and the
introduction of new reproductive technologies. Hum Reprod 2001;16:
215–219.
Van Royen E, Mangelschots K, De Neubourg D, Valkenburg M, Van de
Meerssche M, Ryckaert G, Eestermans W, Gerris J. Characterization of
a top quality embryo, a step towards single-embryo transfer. Hum
Reprod 1999;14:2345–2349.
Van Voorhis BJ, Syrop CH. Cost-effective Treatment for the couple with
infertility. Clin Obstet Gynecol 2000;43:958–973.
Van Voorhis BJ, Sparks AET, Allen BD, Stovall DW, Syrop CH, Chapler FK.
Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril
1997;67:830–836.
van Zandvoort H, de Koning K, Gerrits T. Medical infertility care in low
income countries: the case of concern in policy and practice. Trop Med
Int Health 2001;6:563–569.
Vayena E, Rowe PJ, Grifﬁn PD (eds). Current Practices and Controversies in
Assisted Reproduction. Report of a Meeting. Geneva, Switzerland: World
Health Organization, 2002a,383–385.
Vayena E, Rowe JP, Peterson HB. Assisted reproductive technology in
developing countries: why should we care? Fertil Steril 2002b;78:
13–15.
Verhulst SM, Cohlen BJ, Hughes E, te Velde E, Heineman MJ. Intra-uterine
insemination for unexplained subfertility. Cochrane Database Syst Rev
2006;4:CD001838.
Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem
A, Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/
ICSI: a pilot study. Reprod Biomed Online 2006;13:166–172.
Walker U, Hoﬂer W. Prevalence of Chlamydia trachomatis in pregnant women
andinfertilitycasesinAbeokuta,Nigeria.TropMed Parasit1989;40:77–81.
Widge A. Sociocultural attitudes towards infertility and assisted reproduction
in India. In: Vayena E, Rowe PJ, Grifﬁn PD (eds). Current Practices
and Controversies in Assisted Reproduction. Geneva, Switzerland
World Health Organization, 2002,60–74.
Wiersema NJ, Drukker AJ, Dung MBT, Nhu GH, Nhu NT, Lambalk B.
Consequences of infertility in developing countries: results of a
questionnaire and interview survey in the south of Vietnam. J Transl
Med 2006;4:54–61.
Wolner-Hanssen P, Rydhstroem H. Cost-effectiveness analysis of in-vitro
fertilization: estimated costs per successful pregnancy after transfer of
one or two embryos. Hum Reprod 1998;13:88–94.
World Health Organization. Infections, pregnancies and infertility:
perspectives on prevention. Fertil Steril 1987;47:944–949.
Ombelet et al.
620World Health Organization. Infertility: A Tabulation of Available Data on
Prevalence of Primary and Secondary Infertility. Geneva: WHO,
1991,WHO/MCH/91.9.
World Health Organization. WHO Laboratory Manual for the Examination of
Human Semen and Sperm-cervical Mucus Interaction. 4th edn.
Cambridge, UK: Cambridge University Press, 1999.
World Health Organization. Unsafe Abortion: Global and Regional Estimates
of the Incidence of Unsafe Abortions and Associated Mortality in 2000.
4th edn. Geneva, Switzerland: WHO, 2004.
World Health Organization.Female Genital Mutilation. 2005. Fact sheet No241
(June 2000). http//:www.who.int/mediacenter/factssheets/fs241/en.
World Health Organization. World Health Statistics: 2007. Geneva, 2007.
http://www.who.int/whosis/whostat2007/en/index.htlm.
Yokoyama Y, Shimizu T, Hayakawa K. Incidence of handicaps in multiple
births and associated factors. Acta Genet Med Gemellol (Roma) 1995;
44:81–91.
Zayed F, Lenton EA, Cooke ID. Comparison between stimulated in-vitro
fertilization and stimulated intrauterine insemination for the treatment of
unexplained and mild male factor infertility. Hum Reprod 1997;12:
2408–2413.
Zegers-Hochschild F, Schwarze J-E, Galdames V. Assisted reproductive
technology in Latin America: an example of regional cooperation and
development. Hum Reprod ESHRE Monograph 2008;5:42–47.
Submitted on May 6, 2008; resubmitted on August 5, 2008; accepted on
August 13, 2008
Developing countries and infertility
621